Difficulty: Medium
Average Score: 81%
Practice
A 65-year-old female with osteoporosis is prescribed raloxifene. Raloxifene works by:
Correct answer
A
Rationale
In this scenario, the correct answer is A) Inhibiting osteoclast activity. Raloxifene is a selective estrogen receptor modulator (SERM) that works by binding to estrogen receptors in the bone, mimicking the effects of estrogen. By doing so, it inhibits osteoclast activity, which are cells responsible for bone resorption.
Option B) Increasing calcium absorption in the intestines is incorrect because raloxifene does not directly affect calcium absorption. Option C) Increasing bone formation by osteoblasts is incorrect as raloxifene primarily acts on inhibiting bone resorption rather than directly stimulating bone formation. Option D) Inhibiting collagen synthesis is incorrect as raloxifene does not have a direct effect on collagen synthesis in bone.
Educationally, understanding how medications work in treating conditions like osteoporosis is crucial for healthcare professionals to provide effective care. Knowing the mechanism of action of medications helps in making appropriate treatment decisions and monitoring for potential side effects or interactions. This knowledge is essential for pharmacists, nurses, and other healthcare providers involved in managing patients with osteoporosis.
Option B) Increasing calcium absorption in the intestines is incorrect because raloxifene does not directly affect calcium absorption. Option C) Increasing bone formation by osteoblasts is incorrect as raloxifene primarily acts on inhibiting bone resorption rather than directly stimulating bone formation. Option D) Inhibiting collagen synthesis is incorrect as raloxifene does not have a direct effect on collagen synthesis in bone.
Educationally, understanding how medications work in treating conditions like osteoporosis is crucial for healthcare professionals to provide effective care. Knowing the mechanism of action of medications helps in making appropriate treatment decisions and monitoring for potential side effects or interactions. This knowledge is essential for pharmacists, nurses, and other healthcare providers involved in managing patients with osteoporosis.